Stroke/Cerebrovascular Disease

Stroke/Cerebrovascular Disease News

  • Dual Antiplatelet Therapy Reduces Stroke Recurrence Risk Compared to using just one antiplatelet drug, dual antiplatelet therapy started soon after ischemic stroke reduced the risk of recurrence without increasing the risk of major bleeding.
  • Vorapaxar Meets End Point But Ups Bleeding In its second phase 3 trial, Merck's novel antiplatelet agent reduced ischemic events but increased bleeding, including ICH. Results looked more promising in patients without a history of stroke.
 

Stroke/Cerebrovascular Disease Perspectives

 

Journals

 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.